跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26,550 条关于
“extremity arterial injury”
全部
26,550
临床试验
24,579
药物
148
机构
18
资讯
1,805
12天前
Humacyte's Symvess Shelf Life Extended to 36 Months Following FDA Authorization
去年
Humacyte's Symvess Receives FDA Approval for Vascular Repair, Stock Soars
去年
Humacyte's Symvess Demonstrates 92% Patency Rate in Hospital-Acquired Vascular Complications Study
去年
Trestle Bio and Humacyte Partner to Develop Bioengineered Kidney Tissues with Vascular Perfusion
去年
Robotic Rehabilitation Optimized with AI for Stroke Patients
去年
Humacyte's Bioengineered Vessel SYMVESS Receives FDA Approval for Extremity Vascular Trauma
去年
Sorafenib-TACE Outperforms Lenvatinib-TACE in Intermediate HCC
去年
Humacyte's Tissue-Engineered Vessel Shows Promise in Emergency Vascular Repair
去年
NervGen Nears Enrollment Completion in Spinal Cord Injury Trial of NVG-291
2年前
NervGen Pharma Highlights Clinical Trial Challenges in Spinal Cord Injury at U2FP Symposium
第 1 页,共 181 页
上一页
下一页